Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention

Acta Pharmacologica Sinica

Volumn 28, Issue 3, 2007, Pages 339-343

  Yan, Jin Chuan ^a   Ding, Shu ^a   Liang, Yi ^a   Ma, Gen Shan ^b   Zhu, Jian ^b   Feng, Yi ^b   Luo, Dan ^b  

^a JIANGSU UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

CD40; CD40 ligand; Percutaneous coronary intervention; Restenosis

Indexed keywords

C REACTIVE PROTEIN; CD40 ANTIGEN;

ADULT; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN EXPRESSION; RESTENOSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE; TRANSLUMINAL CORONARY ANGIOPLASTY; UPREGULATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTIGENS, CD40; BLOOD PLATELETS; C-REACTIVE PROTEIN; CD40 LIGAND; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MICE; UP-REGULATION;

EID: 33847189235     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00520.x     Document Type: Article

References (20)

1. Salgado FW, Martinez FE, Horta P, Lemos PA, Migueletto BC, Serrano CVJ, et al. Intracoronary inflammatory markers after percutaneous coronary interventions. Arg Bras Cardiol 2005; 85: 180-5.
2. Phipps RP. Atherosclerosis: the emerging role of inflammmation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930-2.
3. Yan JC, Wu ZG, Li L, Zhong RQ, Kong XT. The clinical implications of increased expression of CD40L in patients with acute coronary syndromes. Chin Med J 2002; 115: 491-3.
4. Yan JC, Wu ZG, Kong XT, Zhong RQ, Zhan LZ. Relation between upregulation of CD40-CD40 ligand system and serum levels of matrix metalloproteinases and complex stenosis morphology in patients with acute coronary syndrome. Acta Pharmacol Sin 2004; 25: 251-6.
5. Yan JC, Wu ZG, Li L, Zhong RQ, Kong XT. The relation between expression of CD40-CD40 ligand system and serum cholesterol levels in patients with hypercholesterolemia. Chin Med J 2004; 117: 1101-3.
6. Yan JC, Zhu J, Gao L, Ma GS, Wu ZG, Kong XT. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clin Chim Acta 2004; 343: 155-9.
7. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327-34.
8. Yan JC, Wu ZG, Chen JM, Li L, Kong XT. Upregulation of CD40-CD40L ligand system in patients with diabetes mellitus. Clin Chim Acta 2004; 339: 85-90.
9. Michelson AD, Barnard MR, Krueger LA, Frelinger AL III, Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000; 21: 259-70.
10. Kivela A, Hartikainen J. Restenosis related to percutaneous coronary intervention has been solved? Ann Med 2006; 38: 173-87.
11. Bhatt DL, Topol EJ. Need to test the arterial inflammation hypothesis. Circulation 2002; 106: 136-40.
12. Cipollone F, Ferri F, Desideri G, Paloscia L, Materazzo G, Mascellanti M, et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003; 108: 2776-82.
13. Cipollone F, Mezzetti A, Porreca E, Di Febbo C, Nutini M, Fazia M, et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation 2002; 106: 399-402.
14. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106: 896-9.
15. Yan JC, Ma GS, Wu ZG, Li L, Kong XT, Zong RQ, Zhan LZ. Increased levels of CD40-CD40 ligand system in patients with essential hypertension. Clin Chim Acta 2005; 355: 191-6.
16. de Winter RJ, Heyde GS, Koch KT, Fischer J, van Straalen JP, Bax M, et al. The prognostic value of pre-procedural plasma Creactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 2002; 23: 960-6.
17. Kwaijtaal M, van Diest R, Bar FW, van der Ven AJ, Bruggeman CA, de Baets MH, et al. Inflammatory markers predict late cardiac events in patients who are exhaust after percutaneous coronary intervention. Atherosclerosis 2005; 182: 341-8.
18. Tanne D, Haim M, Goldbourt U, Bovko V, Reshef T, Adler Y, et al. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease. Int J Cardiol 2006; 107: 322-6.
19. Turker S, Guneri S, Akdeniz B, Ozcan MA, Baris N, Badak O, et al. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Am J Cardiol 2006; 97: 198-202.
20. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89: 1092-103.